Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
FDA unveils new plan for genome therapy editing
The guidance allows sponsors to build on data generated from previous R&D programmes.
Read more
AstraZeneca bets big on China with $15bn investment
Pascal Soriot, CEO, AZ, hailed the investment as the start of “an exciting next chapter” for the company in China.
TrumpRx: Guidance on DTC sales issued to industry
The Office of Inspector General’s bulletin provides a framework for pharma companies selling prescription drugs direct-to-consumers (DTC).
US government negotiates Medicare part B drugs
The CMS has unveiled the 15 high-cost medications selected for the next phase of the Medicare Drug Price Negotiation Program.
When ELNs fall short: why R&D is turning to AI
A new study shows how limitations in electronic lab notebooks (ELNs) are driving pharma R&D teams to use AI tools, raising privacy concerns.
Gen Z increasingly turning to AI for STI advice
A growing number of Gen Z are turning to AI chatbots for sexual health advice, including the diagnosis of sexually transmitted infections.
Major philanthropies launch $60m AMR consortium
This first-of-its-kind global consortium aims to accelerate the discovery of treatments for the world’s most resistant pathogens.
New drug could offer another way to treat stroke
Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.
Paracetamol safety: New study finds no autism link
A review has provided evidence debunking claims that acetaminophen (paracetamol) use during pregnancy increases the risk of ASDand ADHD.
Loading posts...
« Previous
1
…
10
11
12
13
14
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View